ALB and neoplasm: Univariate survival analysis for patients in the propensity score model showed the following predictors of poor prognosis: age < 65 years, serum albumin < 4 g/dL, bilirubin ≥ 1 mg/dL, AFP level ≥ 400 ng/mL, tumor size > 10 cm, presence of PVTT, and TACE treatment (all p<0.1).